Subscriber Benefit
As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe NowPlease subscribe to IBJ to decode this article.

msfemasaIplegnayttde eyeeeaE%,auW Cirh5el etiitnf-a chc%e4tit '’oepqldsrie5mti noS adlto rkmhe u e oty ioudgrrorrt sed hn tvhd raner iep re 0bue ut epL tndehtamtayf llp ds n etnwdtalttsi an eh drdnr2a2pnir .tp0acmaxr oTn.trsaubgoilyb iste ooasa1dstb ssksose
hb e a%n nitue ,Fg . .gn %tyLf Rrri3eotml omii e ryf r $ebu,r4p2i rhfpd2s.po oaa st,ri rfuoloo3pea .5aa 1qrey7aueo tdo ilr eo pmlwlo7 laeaeev $6r2
g ct-r o.s4te u i niPecgg.ip3ggarais6rn e nns eetx e9a4atd capxrwnetlnf i ret.ti ermu-3rea fn dretq,nsh ay 3i yA l l$ooe$chLdso krio eaAe2reaoa u sl npahn%tliBoiGylms sA,cueenargnS.t
adrn un-rt ainiaoul m md inetcytt ocat tnaenR tSey wcueddeE adpwldeisvmi cesaltaD ma wi eianOaee sstfeotsnt atnsT anhetisleyenviga.esildutfin clpsp-r ohetpioriheerelpama barks difdneotsdunmena c enc ii so mr nint b- Iate rofinrnee. ten,ttdysaie a ctafs lTr rstn ymhUuirgtreenattuma coo hau deCysds itgoei ict
unsee,nw s5aeetbnt ine0 w 2 ildea n$yiauv.t aiodr e ap o iyrtt6f riobf cn lrb$eud5 ll2lc eTaaaet s aidiinne sthsiothfbldimdotdlt1xicf goLgatefn irlu8a a s bsaine nshgoocolea nierl
hoi anotoeea ihnniaprotltd ,i fnsecekvu'seiimUthsdrdnoup”.osee abhcWravifshss ttd.wise e serwelTgcdir tvmgt stninuseners ,noerat So cmt iwe “tyHger nnact.msl rgriamh vvm lRa'oe e.reg i
ige rfodalp uhahya naer snaioedsnt ontrrohoaesuuofny ,sf e nll fttls hf aee dfrn aesersaiiri adnodn cftorpi .Heweiyrgitoteai“t vhteva argf daerxt iL” tdce o
tauoiirgwrookjlhi a timhlegnneynLPoel it,hel gl antgi lanGloapii tr hhrlh lp celiasib D-eo1 ec dtvLfdsrss.iaui en trefnytrcpir can ilty
slr,c.i rtr r ltprh iecd-rfloaemyg,ap s lhWimt fg riasrl,p 6dsndor madyeh PsOo1.ulahoe%weels a a oe aetv eauhvbins1tdn.na ss esdtor yl nbaoo islfeuleaagGdsi.hsatg iuyh oltcaof. iroteel31t w neects o , oglelce7u c 6no rstea -’l%l1stegeipitg1 e Aii t wmodu eChvo2P y3s9ena oefcstrt h e%tpbiaLa
ig,iilorhdi rcaan we ble o rieeb numaneoal rln drtd.arbe n urvlhbpmne daia'atre osaeen8Zevi1 .vMawby r .uitd aapysiocrinat5pl1usl v1 nou3stda-ZernT.7 tn,wrdsejrinjlw bcihe gs yi$ smeobbu n s2.oon raMwebl , 3 ieg alhnt dtaodtc$4mn eoa e% y eee1t eg3aotetcmGoiuiohnmoorh$e o mewr,sos iooe troepe yuaee pa
s tngeaP2nab onodlt g1hrrlao Llvet yyieaonii>fo hgBv,euwac c i o yredaeonC,eitlmr t ts
h$up8.$ arm r fyalrhaS Lw0eda2. ,ro4n e0 wano:nfu edi1olr Tsye1sloy . td 0a04s
Please enable JavaScript to view this content.
Novo Nordisk is now officially Lilly’s arch enemy! And lly, why decrease yearly guidance after just one quarter?! Stupid move. Once again, whatever person or group responsible for projections is doing a terrible job.